We have previously demonstrated that CHSY1 functions as the dominant CS synthase in human glioma cells, and its expression is significantly correlated with the anti-CS antibody (CS56) staining intensity in glioma tissues [17]. The gene discussed is CS; the disease is central nervous system cancer.